Product Description
The global stereotactic device market was valued at approximately $490 million in 2025. This is expected to increase over the forecast period at a CAGR of 3.6% to reach about $630 million by 2032.
The full report suite on the global stereotactic device market includes stereotactic devices includes analysis of procedures, units sold, ASP, market value and competitor market share.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Stereotactic Device Market Trends

The stereotactic device market is expected to grow steadily over the forecast period, driven by increasing unit sales. While average selling prices decline slightly due to pricing pressures, overall market value continues to rise as volume growth offsets these declines. Growth rates gradually slow over time, reflecting a maturing market.
Global Stereotactic Device Market Share Insights

- Medtronic was the leader in the global stereotactic device market in 2025. The company competes with its StealthStation®
- Brainlab held the second-leading position in the stereotactic device market. The company offers the iPlan® RT system for advanced stereotactic planning, which can be used for daily clinical use or advanced clinical research.
- Stryker was the third-leading competitor in the stereotactic device market in 2025. The company offers a CranialMask Tracker to be used with its CrainialMap 0 software to incorporate navigation into neurosurgical procedures.
Global Stereotactic Device Market Segmentation Summary
- Aneurysm Clip Market – Further Segmented Into:
- Material Type: Frame-Based and Frameless.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.